Search

Search Constraints

You searched for: Author/Creator Shain, Kenneth H.

Search Results

2. Efficacy and safety results from a phase 1b/2, multicenter, open-label study of oprozomib and dexamethasone in patients with relapsed and/or refractory multiple myeloma. (August 2019)

3. Lenalidomide‐based response‐adapted therapy for older adults without high risk myeloma. (12th December 2018)

4. Phase II study of pegylated liposomal doxorubicin, low‐dose dexamethasone, and lenalidomide in patients with newly diagnosed multiple myeloma. Issue 1 (January 2014)

5. Recurrent cardiotoxicity potentiated by the interaction of proteasome inhibitor and immunomodulatory therapy for the treatment of multiple myeloma. (19th October 2017)

6. Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomide. Issue 3 (4th March 2017)

7. Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide. (20th April 2016)